Related references
Note: Only part of the references are listed.Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy
Emidio E. Pistilli et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Evaluation of Adeno-Associated Viral Vectors for Liver-Directed Gene Transfer in Dogs
Peter Bell et al.
HUMAN GENE THERAPY (2011)
CHANGES IN MUSCLE T2 AND TISSUE DAMAGE AFTER DOWNHILL RUNNING IN mdx MICE
Sunita Mathur et al.
MUSCLE & NERVE (2011)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Gene therapy for muscle disease
Yuko Miyagoe-Suzuki et al.
EXPERIMENTAL CELL RESEARCH (2010)
Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
Richard S. Finkel
JOURNAL OF CHILD NEUROLOGY (2010)
The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
Terence Partridge
JOURNAL OF CHILD NEUROLOGY (2010)
Persistent Expression of FLAG-tagged Micro-dystrophin in Nonhuman Primates Following Intramuscular and Vascular Delivery
Louise R. Rodino-Klapac et al.
MOLECULAR THERAPY (2010)
Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
Joe N. Kornegay et al.
MOLECULAR THERAPY (2010)
ACTIVIN IIB RECEPTOR BLOCKADE ATTENUATES DYSTROPHIC PATHOLOGY IN A MOUSE MODEL OF DUCHENNE MUSCULAR DYSTROPHY
Kevin J. Morine et al.
MUSCLE & NERVE (2010)
Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice
Kevin J. Morine et al.
PLOS ONE (2010)
A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping
Gemma L. Walmsley et al.
PLOS ONE (2010)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
Hydrodynamic Limb Vein Injection of Adeno-Associated Virus Serotype 8 Vector Carrying Canine Myostatin Propeptide Gene into Normal Dogs Enhances Muscle Growth
Chunping Qiao et al.
HUMAN GENE THERAPY (2009)
Gene Therapy in Large Animal Models of Muscular Dystrophy
Zejing Wang et al.
ILAR JOURNAL (2009)
Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy
Hermien E. Kan et al.
NEUROMUSCULAR DISORDERS (2009)
A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy
Kathryn R. Wagner et al.
ANNALS OF NEUROLOGY (2008)
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice
Michela Alessandra Denti et al.
HUMAN GENE THERAPY (2008)
Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice
Chunping Qiao et al.
HUMAN GENE THERAPY (2008)
Myostatin directly regulates skeletal muscle fibrosis
Zhao Bo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C
Sasha Bogdanovich et al.
MUSCLE & NERVE (2008)
Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2D
Christina A. Pacak et al.
MOLECULAR THERAPY (2007)
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Federico Mingozzi et al.
BLOOD (2007)
Sprinting without myrostatin: a genetic determinant of athletic prowess
Se-Jin Lee
TRENDS IN GENETICS (2007)
Quadrupling Muscle Mass in Mice by Targeting TGF-β Signaling Pathways
Se-Jin Lee
PLOS ONE (2007)
AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency
M. Bartoli et al.
GENE THERAPY (2007)
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression
Zejing Wang et al.
MOLECULAR THERAPY (2007)
Myostatin does not regulate cardiac hypertrophy or fibrosis
Ronald D. Cohn et al.
NEUROMUSCULAR DISORDERS (2007)
Contractile properties of EDL and soleus muscles of myostatin-deficient mice
Christopher L. Mendias et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
MA Denti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization of alterations in diabetic myocardial tissue using high resolution MRI
R Loganathan et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2006)
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology
S Bogdanovich et al.
FASEB JOURNAL (2005)
Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury
MJ Liu et al.
MOLECULAR THERAPY (2005)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Brief report -: Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Regulation of muscle mass by myostatin
SJ Lee
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases
NM Wolfman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Origins and early descriptions of Duchenne muscular dystrophy
KL Tyler
MUSCLE & NERVE (2003)
Canine X-linked muscular dystrophy in Japan (CXMDj)
Y Shimatsu et al.
EXPERIMENTAL ANIMALS (2003)
Dystrophin and mutations: one gene, several proteins, multiple phenotypes
F Muntoni et al.
LANCET NEUROLOGY (2003)
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
KR Wagner et al.
ANNALS OF NEUROLOGY (2002)
Functional improvement of dystrophic muscle by myostatin blockade
S Bogdanovich et al.
NATURE (2002)
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
ER Barton et al.
JOURNAL OF CELL BIOLOGY (2002)
Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
SQ Harper et al.
NATURE MEDICINE (2002)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
DM McCarty et al.
GENE THERAPY (2001)
Share Paper
